Skip to content
healthcare.dev

Lisdexamfetamine Dimesylate

NDC 64850-552, lisdexamfetamine dimesylate, capsule, from Elite Laboratories, Inc..

Product NDC
64850-552
Status
Listed
Labeler
Elite Laboratories, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218604
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64850-552 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE30 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
64850-552-0164850055201100 CAPSULE in 1 BOTTLE (64850-552-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0e024b69-567c-4b40-9c3e-a2daec34256c
  • NADAC price for package 64850055201

    GET /v1/drugs/nadac/64850055201

Use it

Look up 64850-552 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64850-552 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64850-552. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.